IndraLab

Statements


MYSM1 dephosphorylates RIPK2 on S176. 2 / 2
| 2

sparser
"Mechanistically, MYSM1 deubiquitinates and dephosphorylates RIPK2 S176 by recruiting PP2A. These findings offer unprecedented evidence of the MYSM1/PP2A/RIPK2 axis’s role in preserving cartilage homeostasis, indicating that targeting MYSM1 and downstream RIPK2 could be therapeutically beneficial for OA treatment."

sparser
"MYSM1 deubiquitinates and dephosphorylates RIPK2 S176 by recruiting protein phosphatase 2 A (PP2A)."